Ciclesonide/Formoterol fumarate

环索奈德/富马酸福莫特罗

Report date: 2025/11/18 14:49:20

Base Information

Drug NameCiclesonide/Formoterol fumarate
Drug Alias Name环索奈德和富马酸福莫特罗Ciclesonide/Formoterol环索奈德•富马酸福莫特罗Ciclesonide-Formoterol fumarate环索奈德-富马酸福莫特罗 +[14] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2007/03/28
Country/TerritorySouth AfricaHungaryGermany +[5] 
CombinationsYes Formoterol FumarateCiclesonide
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBeijing Representative Office Of Ramsey Lab Co Ltd IndiaSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03AK
Related LinksN/A